Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,693Revenue (TTM) $M256Net Margin (%)-1.3Altman Z-Score6.0
Enterprise Value $M1,649EPS (TTM) $-0.1Operating Margin %1.5Piotroski F-Score6
P/E(ttm)--Beneish M-Score-2.8Pre-tax Margin (%)-1.2Higher ROA y-yN
Price/Book7.510-y EBITDA Growth Rate %--Quick Ratio1.3Cash flow > EarningsY
Price/Sales7.15-y EBITDA Growth Rate %--Current Ratio1.7Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %-14.0ROA % (ttm)-0.9Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-1.6Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M37.2ROIC % (ttm)1.2Gross Margin Increase y-yY

Gurus Latest Trades with PCRX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PCRXMariko Gordon 2016-03-31 Add0.05%$45.36 - $76.79
($58.89)
$ 45.56-23%Add 1.57%963,184
PCRXRon Baron 2016-03-31 Add$45.36 - $76.79
($58.89)
$ 45.56-23%Add 25.44%16,211
PCRXMariko Gordon 2015-12-31 Reduce-0.24%$36.62 - $79.39
($57.34)
$ 45.56-21%Reduce -9.00%948,283
PCRXRon Baron 2015-12-31 Add$36.62 - $79.39
($57.34)
$ 45.56-21%Add 87.29%12,923
PCRXKen Fisher 2015-12-31 Add$36.62 - $79.39
($56.9)
$ 45.56-20%Add 4.15%6,197
PCRXMariko Gordon 2015-09-30 Add0.94%$40.95 - $70
($61.25)
$ 45.56-26%Add 56.02%1,042,012
PCRXGeorge Soros 2015-09-30 Sold Out -0.39%$40.95 - $70
($61.25)
$ 45.56-26%Sold Out0
PCRXRon Baron 2015-09-30 Buy $40.95 - $70
($61.25)
$ 45.56-26%New holding6,900
PCRXKen Fisher 2015-09-30 Add$40.95 - $70
($61.25)
$ 45.56-26%Add 23.96%5,950
PCRXGeorge Soros 2015-06-30 Buy 0.39%$65.78 - $92.39
($78.91)
$ 45.56-42%New holding531,800
PCRXRon Baron 2015-06-30 Sold Out -0.03%$65.78 - $92.39
($78.91)
$ 45.56-42%Sold Out0
PCRXMariko Gordon 2015-06-30 Add0.02%$65.78 - $92.39
($78.91)
$ 45.56-42%Add 1.19%667,877
PCRXJoel Greenblatt 2015-06-30 Sold Out -0.01%$65.78 - $92.39
($78.91)
$ 45.56-42%Sold Out0
PCRXMariko Gordon 2015-03-31 Reduce-0.12%$85.01 - $119.27
($101.46)
$ 45.56-55%Reduce -4.30%659,998
PCRXGeorge Soros 2015-03-31 Sold Out -0.084%$85.01 - $119.27
($101.46)
$ 45.56-55%Sold Out0
PCRXJoel Greenblatt 2015-03-31 Buy 0.01%$85.01 - $119.27
($101.46)
$ 45.56-55%New holding9,319
PCRXRon Baron 2015-03-31 Add0.01%$85.01 - $119.27
($101.46)
$ 45.56-55%Add 22.79%82,380
PCRXMariko Gordon 2014-12-31 Reduce-0.54%$86.02 - $107.8
($94.65)
$ 45.56-52%Reduce -15.33%689,628
PCRXGeorge Soros 2014-12-31 Buy 0.08%$86.02 - $107.8
($94.65)
$ 45.56-52%New holding87,000
PCRXJoel Greenblatt 2014-12-31 Sold Out -0.01%$86.02 - $107.8
($94.65)
$ 45.56-52%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PCRX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PCRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
STACK DAVID MCEO and Chairman 2016-04-15Sell25,000$64.14-28.97view
HASTINGS PAUL JDirector 2016-02-17Sell3,000$60-24.07view
Braunstein ScottSVP, Strategy & Corp. Dev. 2016-01-29Buy2,000$58.92-22.67view
Jones James BSVP & Chief Medical Officer 2016-01-27Buy500$62.5-27.1view
STACK DAVID MCEO and Chairman 2016-01-15Sell15,000$63.84-28.63view
LONGENECKER JOHN P PHDDirector 2016-01-12Buy300$66.55-31.54view
Jones James BSVP & Chief Medical Officer 2016-01-12Buy1,000$66-30.97view
HASTINGS PAUL JDirector 2015-11-20Sell3,000$60-24.07view
STACK DAVID MPresident, CEO and Chairman 2015-10-15Sell15,000$37.5721.27view
Scibetta James SSVP, CFO 2015-09-11Buy5,000$61.37-25.76view

Press Releases about PCRX :

Quarterly/Annual Reports about PCRX:

News about PCRX:

Articles On GuruFocus.com
Baron Funds Comments on Pacira Pharmaceuticals Inc. May 19 2016 
Baron Funds Comments on Pacira Pharmaceuticals Inc. Feb 25 2016 
Mariko Gordon Nearly Doubles Stake in Forward Air Jan 04 2016 
Wedbush Highlights 2015 Catalysts for Emerging BioPharmaceuticals Feb 04 2015 
Mariko Gordon's First Quarter Top Five May 15 2014 
Baron Funds Comments on Pacira Pharmaceuticals Mar 05 2014 
Weekly CFO Buys Highlight: PCRX, UGI, MIG, GLT, IOSP Feb 27 2011 
Weekly CFO Buys Highlight: REFR, UGI, PCRX, NOIZ Feb 21 2011 
Pacira Pharmaceuticals Inc. (PCRX) CFO James S Scibetta buys 5,000 Shares Feb 16 2011 
Pacira Pharmaceuticals Inc. (PCRX) CEO David M Stack buys 5,000 Shares Feb 11 2011 

More From Other Websites
PACIRA PHARMACEUTICALS, INC. Financials May 06 2016
Pacira Pharmaceuticals, Inc. :PCRX-US: Earnings Analysis: Q1, 2016 By the Numbers May 03 2016
Pacira Pharmaceuticals, Inc. to Present at the Bank of America Merrill Lynch 2016 Health Care... May 03 2016
Pacira Pharmaceuticals, Inc. to Present at the Bank of America Merrill Lynch 2016 Health Care... May 03 2016
Edited Transcript of PCRX earnings conference call or presentation 2-May-16 1:00pm GMT May 02 2016
Pacira Pharmaceuticals Inc Earnings Call scheduled for 9:00 am ET today May 02 2016
PACIRA PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... May 02 2016
Pacira reports 1Q loss May 02 2016
Pacira reports 1Q loss May 02 2016
Pacira Pharmaceuticals, Inc. Reports First Quarter 2016 Financial Results May 02 2016
Q1 2016 Pacira Pharmaceuticals Inc Earnings Release - Before Market Open May 02 2016
Pacira Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : PCRX-US :... Apr 29 2016
Pacira Pharmaceuticals Appoints Charles A. Reinhart, III, as Chief Financial Officer Apr 19 2016
PACIRA PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Apr 19 2016
Pacira Pharmaceuticals Appoints Charles A. Reinhart, III, as Chief Financial Officer Apr 19 2016
Coverage initiated on Pacira Pharma by Mizuho Apr 19 2016
Pacira Pharmaceuticals (PCRX) is Overbought: Is A Drop Coming? Apr 15 2016
Pacira Pharmaceuticals Announces Timing for First Quarter 2016 Financial Results Webcast and... Apr 14 2016
Pacira Pharmaceuticals Announces Timing for First Quarter 2016 Financial Results Webcast and... Apr 14 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)